Determination of the Degree of Esterification in Heparin Benzylates During Synthesis of Enoxaparin, a Domestic Analog of Low-Molecular-Mass Heparin
- Авторы: Frumin L.E.1, Yur’eva K.P.1, Matveev A.V.1, Vorfolomeeva E.V.1,2, Vostrov I.A.2, Zatonskii G.V.3, Prokhorov D.I.1, Zhavoronok E.S.1,2, Panov A.V.1,2, Grebenkina L.E.1, Pyatigorskaya N.V.4, Brkich G.É.4, Kedik S.A.1,2
 - 
							Учреждения: 
							
- M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
 - Institute of Pharmaceutical Technologies
 - G. F. Gause Institute of New Antibiotics
 - I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
 
 - Выпуск: Том 53, № 9 (2019)
 - Страницы: 852-857
 - Раздел: Article
 - URL: https://journals.rcsi.science/0091-150X/article/view/246033
 - DOI: https://doi.org/10.1007/s11094-019-02089-7
 - ID: 246033
 
Цитировать
Аннотация
The esterification stage of low-molecular-mass heparin (enoxaparin) production by hydrolytic depolymerization of unfractionated heparin was studied and consisted of treating previously synthesized benzethonium heparinate with benzyl chloride. The content of benzyl moieties in the synthesized heparin benzylates and their degree of benzylation were determined using HPLC, PMR, and 13C NMR methods. A carboxylic-acid content of 0.13 ± 0.01 mol/g in the starting heparin was calculated from these results. A new method for estimating the degree of heparin benzylation from PMR and HPLC data was proposed. The benzyl content in the heparin benzylates increased with increasing molar excess of benzyl chloride.
Об авторах
L. Frumin
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454						
K. Yur’eva
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
							Автор, ответственный за переписку.
							Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454						
A. Matveev
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454						
E. Vorfolomeeva
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353						
I. Vostrov
Institute of Pharmaceutical Technologies
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							Skolkovo, Moscow, 121353						
G. Zatonskii
G. F. Gause Institute of New Antibiotics
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							11 Bol’shaya Pirogovskaya St., Moscow, 119435						
D. Prokhorov
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454						
E. Zhavoronok
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353						
A. Panov
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353						
L. Grebenkina
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454						
N. Pyatigorskaya
I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							Moscow						
G. Brkich
I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							Moscow						
S. Kedik
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
														Email: kristina.yureva1994@mail.ru
				                					                																			                												                	Россия, 							78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353						
Дополнительные файлы
				
			
						
					
						
						
						
									